Evidence map›Paper›PMID 36987602›Full record

ReviewRheumatology (Oxford, England)2023

The global epidemiology of SLE: narrowing the knowledge gaps.

Megan R W Barber, Titilola Falasinnu, Rosalind Ramsey-Goldman, Ann E Clarke

Open access · hybridAbstract readReview
In one paragraph

Review in Rheumatology (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Megan R W BarberDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-1055-1335
Titilola FalasinnuDivision of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.
Rosalind Ramsey-GoldmanDepartment of Medicine, Division of Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ann E ClarkeDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
University of Calgary · CANorthwestern University · USStanford Medicine · US

Funding

Resource CoreP30AR072579 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Leena Sharma · 2017 to 2026
$8.3M
Northwestern University Clinical and Translational Science Institute (NUCATS)KL2TR001424 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHARMA, LEENA · 2015 to 2023
$8.1M
The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus ErythematosusR01AI170938 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Carla M Cuda · 2022 to 2026
$3.9M
Lupus Intervention Fatigue Trial (LIFT)R01AR071091 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI EHRLICH-JONES, LINDA S., RAMSEY-GOLDMAN, ROSALIND · 2018 to 2022
$3.0M
Characterization of the lupus nephritis microRNAomeR01AR073850 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BROWN, ELIZABETH E · 2018 to 2022
$3.0M
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic DiseasesR01AR080089 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FELDMAN, CANDACE HILLARY, RAMSEY-GOLDMAN, ROSALIND · 2022 to 2024
$2.2M
Characterization of Chronic Pain and its Biopsychosocial Mechanisms in Lupus using Electronic Health RecordsK01AR079039 · NIAMS · STANFORD UNIVERSITY · PI FALASINNU, TITILOLA · 2021 to 2025
$631k
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamineR21AI171491 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAMSEY-GOLDMAN, ROSALIND, ZHAO, MING · 2022 to 2023
$440k
NCATS NIH HHS KL2 TR001424NIAID NIH HHS R01 AI170938NIAID NIH HHS R21 AI171491NIAMS NIH HHS K01 AR079039NIAMS NIH HHS P30 AR072579NIAMS NIH HHS R01 AR071091NIAMS NIH HHS R01 AR073850NIAMS NIH HHS R01 AR080089NIH HHS P30 AR072579
6 · The paper itself

Abstract

SLE is a global health concern that unevenly affects certain ethnic/racial groups. Individuals of Asian, Black, Hispanic and Indigenous ethnicity/race are amongst those who experience increased prevalence, incidence, morbidity and mortality. Population-based surveillance studies from many regions are few and often still in nascent stages. Many of these areas are challenged by restricted access to diagnostics and therapeutics. Without accurately capturing the worldwide burden and distribution of SLE, appropriately dedicating resources to improve global SLE outcomes may be challenging. This review discusses recent SLE epidemiological studies, highlighting the challenges and emerging opportunities in low- and middle-income countries. We suggest means of closing these gaps to better address the global health need in SLE.

Indexed as

EthnicityLupus Erythematosus, SystemicAsian PeopleBlack PeopleHispanic or LatinoHumansMorbidityRacial Groupsepidemiologyhealth disparitiesincidencelow- and middle-income countrieslupusprevalenceSLE

Identifiers

PMID36987602
PMCPMC10050933
OpenAlexW4361195913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.